WallStSmart

Braskem SA Class A (BAK)vsHuntsman Corporation (HUN)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 1047% more annual revenue ($70.60B vs $6.16B). HUN leads profitability with a -2.8% profit margin vs -7.8%. BAK appears more attractively valued with a PEG of 1.46. HUN earns a higher WallStSmart Score of 55/100 (C).

BAK

Hold

48

out of 100

Grade: D+

Growth: 6.7Profit: 4.0Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13

HUN

Buy

55

out of 100

Grade: C

Growth: 6.0Profit: 3.0Value: 4.3Quality: 4.5
Piotroski: 1/9Altman Z: 1.64
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BAK.

HUNOvervalued (-14.5%)

Margin of Safety

-14.5%

Fair Value

$12.28

Current Price

$9.66

$2.62 premium

UndervaluedFair: $12.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAK3 strengths · Avg: 9.3/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-5.4310/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.6%8/10

Revenue surging 21.6% year-over-year

HUN3 strengths · Avg: 8.7/10
Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
17.6%8/10

17.6% revenue growth

EPS GrowthGrowth
20.6%8/10

Earnings expanding 20.6% YoY

Areas to Watch

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$438.33M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Free Cash FlowQuality
$-535.00M2/10

Negative free cash flow — burning cash

HUN4 concerns · Avg: 3.5/10
PEG RatioValuation
2.224/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.644/10

Distress zone — elevated risk

Market CapQuality
$1.71B3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.4%3/10

Operating margin of 0.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : HUN

The strongest argument for HUN centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 17.6% demonstrates continued momentum.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : HUN

The primary concerns for HUN are PEG Ratio, Altman Z-Score, Market Cap.

Key Dynamics to Monitor

BAK carries more volatility with a beta of 0.77 — expect wider price swings.

BAK is growing revenue faster at 21.6% — sustainability is the question.

HUN generates stronger free cash flow (77M), providing more financial flexibility.

Monitor CHEMICALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HUN scores higher overall (55/100 vs 48/100) and 17.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

Huntsman Corporation

BASIC MATERIALS · CHEMICALS · USA

Huntsman Corporation manufactures and sells differentiated organic chemicals globally. The company is headquartered in The Woodlands, Texas.

Visit Website →

Want to dig deeper into these stocks?